Life Transitions

A study published in Frontiers in Public Health and led by Mount Sinai researchers found that postmenopausal women in lower-income neighborhoods experienced up to 3.8 times greater bone mineral density loss from air pollution exposure than women in wealthier areas, based on data from 9041 participants in the Women's Health Initiative.

The Policy Center for Maternal Mental Health's 2026 report cards show a slight national grade improvement to a "C," though a new parental support domain returned an "F" across the United States.

A prospective observational study found that age did not independently affect bone mineral density response to romosozumab in postmenopausal women.

A study found no clear evidence that menopause hormone therapy increases or reduces dementia risk.

Check out the 5 biggest menopause stories of 2025, and review best practices.

A US study of women over 60 found that frequent sex toy use during masturbation was strongly associated with higher orgasm frequency.

Study finds trouble sleeping, sleep apnea, and short or long sleep duration are linked to higher odds of hypertension in postmenopausal women.

Survey reveals nearly 40% of women feel misdiagnosed during perimenopause, highlighting critical gaps in women's health care and treatment approaches.

Higher waist-to-hip ratio was linked to poorer cognitive performance in early postmenopause, though it did not alter hormone therapy effects.

FDA updates labeling for menopausal hormone therapy, removing broad boxed warnings and adding guidance for younger symptomatic patients.

A study found that taking as few as 4000 steps per day on just 1 to 2 days each week significantly reduces mortality in women aged 62 years and older.

Explore innovative menopause management strategies for BRCA carriers, including testosterone therapy, to alleviate symptoms and enhance quality of life.

Research at The Menopause Society 2025 meeting highlighted safety, education, and individualized care in menopause management.

Experts discuss contraindications to hormone therapy and evolving care for women with early or surgical menopause, emphasizing individualized treatment.

Experts review updated VMS treatment guidelines and stress shared decision-making to personalize hormone and nonhormone therapy options.

Experts emphasize normalizing menopause discussions early to reduce stigma and improve communication in both clinical and workplace settings.

Experts discuss how culture, stigma, and inequities shape menopause care and leave many women without adequate symptom management.

Experts highlight education, equity, and access gaps in vasomotor symptom care, calling for stronger clinician training and awareness.

Experts discuss updates in the management of vasomotor symtpoms in menopause, including unmet needs, quality of life impacts, and new therapies.

Erin Donnelly Michos, MD, discusses optimizing cardiovascular disease prevention in women through earlier risk assessment and tailored management.

Earlier menopause accelerates memory decline in women with APOE ε4 or inflammation, highlighting sex-specific Alzheimer disease risk factors.

Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.

Early intervention during perimenopause can prevent long-term osteoporosis through timely screening and intermittent therapy strategies.

A systematic review found estrogen-based hormone therapy did not consistently reduce anxiety or depression in midlife women.

A new study finds that earlier menopause and reduced cardiac function may together worsen brain health, highlighting dementia risk factors.